TIGC Symposium 2009
Advances in Oral Anticogulation Treatment Emphasis on Atrial Fibrillation
Metropolitan Hotel, Vancouver, British Columbia December 10, 2009
Learning Objectives:
- Review ongoning and recently complete trials involving alternatives to warfrin.
- To update clinicians on the diagnosis and management of TIA.
- Understand the pivotal role of thrombin in the coagulation cascade.
- Understand the need for oral anticoagulation as chronic therapy in appropriately selected patients.
- Understand the choke points in the coagulation cascade that allow inhibition of thrombin formation.
- To review the importance of atrial fibrillation as a stroke risk.
- To review the current antithrombotic therapies for stroke prevention.
- To review the pharmacology of new oral anticogulants and to have an understanding of their risks and benifits in the prophylaxis and treatment venous thromboemblism.
|
